Award
Delivery Order #SPE2DR26FA2GD
Pharmaceutical Delivery Order for AmerisourceBergen Drug Corp
Buyer
Defense Logistics Agency
Award Amount
$839.48
Ceiling
$839.48
Awarded
March 09, 2026
Period of Performance
Mar 09, 2026 – Mar 10, 2026
Identifier
SPE2DR26FA2GD
NAICS
424210
This award is a delivery order contract issued under an existing indefinite delivery vehicle (IDV) focused on pharmaceutical distribution. The recipient, AmerisourceBergen Drug Corp, is a prominent global pharmaceutical sourcing and distribution company, recognized for providing efficient delivery of medications and healthcare products. The award involves the procurement of a specific pharmaceutical product, Quillivant XR, a suspension medication used in healthcare settings. This contract supports the agency's ongoing pharmaceutical supply chain needs with a precise and timely delivery, emphasizing the importance of consistent medication availability for health services. The scope includes the delivery of the specified pharmaceutical product to a location in Conshohocken, PA, within a very short performance period, reflecting immediate agency needs. This award was issued as a follow-on task under a competitive, multi-year agreement to ensure continuity of supply. The timeline for this delivery order is brief, covering a designated two-day period in early March 2026, highlighting a targeted and specific procurement action.
Description
4571087374!QUILLIVANT XR 25 MG/5 ML SUSP 180ML